OOIR: Observatory of International Research

Papers

(The median citation count of ASAIO Journal is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization	269
Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Provider	268
Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO)	264
Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure	239
Extracorporeal Cardiopulmonary Resuscitation in Adults. Interim Guideline Consensus Statement From the Extracorporeal Life Support Organization	194
ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients	145
2021 ELSO Adult and Pediatric Anticoagulation Guidelines	142
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients	133
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China	128
Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review	114
Noninvasive Neurological Monitoring in Extracorporeal Membrane Oxygenation	82
Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock	61
Extracorporeal Life Support Organization (ELSO): Guidelines for Neonatal Respiratory Failure	58
New Surgical Circulatory Support System Outcomes	58
Extracorporeal Life Support Organization (ELSO): 2020 Pediatric Respiratory ELSO Guideline	57
The Creation of a Pediatric Health Care Learning Network: The ACTION Quality Improvement Collaborative	56
ELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits	55
Successful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation	52
Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO—A “Living Working Document”	38
Artificial Intelligence Algorithm for Screening Heart Failure with Reduced Ejection Fraction Using Electrocardiography	36
Management of Congenital Diaphragmatic Hernia Treated With Extracorporeal Life Support: Interim Guidelines Consensus Statement From the Extracorporeal Life Support Organization	33
Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation	32
First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygena	31
Extracorporeal Life Support Organization (ELSO): Guidelines for Pediatric Cardiac Failure	30
Extracorporeal Membrane Oxygenation in Children with Coronavirus Disease 2019: Preliminary Report from the Collaborative European Chapter of the Extracorporeal Life Support Organization Prospective Su	29

Thrombotic Risk of Rotor Speed Modulation Regimes of Contemporary Centrifugal Continuous-flow Left Ventricular Assist Devices	29
Aloe Vera–Derived Gel-Blended PHBV Nanofibrous Scaffold for Bone Tissue Engineering	29
Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory Therapy	28
SARS-CoV-2 Versus Influenza-associated Acute Respiratory Distress Syndrome Requiring Veno-venous Extracorporeal Membrane Oxygenation Support	27
A Dual-Lumen Percutaneous Cannula for Managing Refractory Right Ventricular Failure	27
COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support	25
Extracorporeal Life Support in Accidental Hypothermia with Cardiac Arrest—A Narrative Review	24
Pediatric Extracorporeal Cardiopulmonary Resuscitation ELSO Guidelines	24
Impella 5.5 Versus Centrimag: A Head-to-Head Comparison of Device Hemocompatibility	23
Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation	22
Heparin-Free Extracorporeal Life Support Using Tethered Liquid Perfluorocarbon: A Feasibility and Efficacy Study	22
Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation	21
Outcomes Associated with Obesity in Patients Undergoing Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis	21
Extracorporeal Membrane Oxygenation for COVID-19 Respiratory Distress Syndrome: An Italian Society for Cardiac Surgery Report	21
Multi-institutional Analysis of 100 Consecutive Patients with COVID-19 and Severe Pulmonary Compromise Treated with Extracorporeal Membrane Oxygenation: Outcomes and Trends Over Time	21
HVAD Usage and Outcomes in the Current Pediatric Ventricular Assist Device Field: An Advanced Cardiac Therapies Improving Outcomes Network (ACTION) Analysis	21
Extracorporeal Life Support Organization Guideline for Transport and Retrieval of Adult and Pediatric Patients with ECMO Support	21
Evaluation of Recirculation During Venovenous Extracorporeal Membrane Oxygenation Using Computational Fluid Dynamics Incorporating Fluid-Structure Interaction	20
Thromboelastometry, Thromboelastography, and Conventional Tests to Assess Anticoagulation During Extracorporeal Support: A Prospective Observational Study	20
A Computational Fluid Dynamics Study of the Extracorporeal Membrane Oxygenation-Failing Heart Circulation	19
Apixaban: Alternative Anticoagulation for HeartMate 3 Ventricular Assist Device	19
Six Month Mortality in Patients with COVID-19 and Non-COVID-19 Viral Pneumonitis Managed with Veno-Venous Extracorporeal Membrane Oxygenation	19
Extracorporeal Life Support Organization (ELSO) Guidelines for Follow-up After Neonatal and Pediatric Extracorporeal Membrane Oxygenation	19
Right–Left Ventricular Interaction in Left-Sided Heart Failure With and Without Venoarterial Extracorporeal Membrane Oxygenation Support—A Simulation Study	17
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist Device	17
Thrombophilia in Pediatric Patients with Multisystem Inflammatory Syndrome in Children Secondary to Coronavirus Disease 2019 Supported on Extracorporeal Membrane Oxygenation	16
Respiratory ECMO Survival Prediction (RESP) Score for COVID-19 Patients Treated with ECMO	16
Outcomes of Extubated COVID and Non-COVID Patients Receiving Awake Venovenous Extracorporeal Membrane Oxygenation	16
Applications of Bacterial Cellulose as a Natural Polymer in Tissue Engineering	16
Effect of Socioeconomic Status on Patients Supported with Contemporary Left Ventricular Assist Devices	15
Tethered Liquid Perfluorocarbon Coating for 72 Hour Heparin-Free Extracorporeal Life Support	15
Early Detection of Pump Thrombosis in Patients With Left Ventricular Assist Device	15
Extubate Before Venovenous Extracorporeal Membranous Oxygenation Decannulation or Decannulate While Remaining on the Ventilator? The EuroELSO 2019 Weaning Survey	15
Ventricular Assist Device Implantation and Bariatric Surgery: A Route to Transplantation in Morbidly Obese Patients with End-Stage Heart Failure	15
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device	15
Extracorporeal Life Support in Hemorrhagic Conditions: A Systematic Review	15
Gender Differences in Mortality After Left Ventricular Assist Device Implant: A Causal Mediation Analysis Approach	15
Less Invasive Left Ventricular Assist Device Implantation Is Safe and Reduces Intraoperative Blood Product Use: A Propensity Score Analysis VAD Implantation Techniques and Blood Product Use	14
Long-Term Health-Related Quality of Life After Venovenous Extracorporeal Membrane Oxygenation	14
Thrombosis in Extracorporeal Membrane Oxygenation (ECMO) Circuits	14
Intraventricular Flow Patterns in Patients Treated with Left Ventricular Assist Devices	14
Impact of Durable Ventricular Assist Device Support on Outcomes of Patients with Congenital Heart Disease Waiting for Heart Transplant	14
Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients	14
Diagnosis and Treatment Strategies of Outflow Graft Obstruction in the Fully Magnetically Levitated Continuous-Flow centrifugal Left Ventricular Assist Device: A Multicenter Case Series	14
Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience	14
Early Usage of Extracorporeal Membrane Oxygenation in the Absence of Invasive Mechanical Ventilation to Treat COVID-19-related Hypoxemic Respiratory Failure	14
Impact of Noninvasive Respiratory Support in Patients With COVID-19 Requiring V-V ECMO	14
Influence of Different Antithrombotic Regimens on Platelet-Mediated Thrombin Generation in Patients with Left Ventricular Assist Devices	14
On the Academic Value of 30 Years of the Extracorporeal Life Support Organization Registry	13
Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients	13

Dynamics of Blood Flows in Aortic Stenosis: Mild, Moderate, and Severe	13
Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation	13
Multicenter Registry Using Propensity Score Analysis to Compare a Novel Transport/Preservation System to Traditional Means on Postoperative Hospital Outcomes and Costs for Heart Transplant Patients	13
Effect of Cytokine Adsorption on Survival and Circulatory Stabilization in Patients Receiving Extracorporeal Cardiopulmonary Resuscitation	13
Breathing Life Back Into the Kidney—Continuous Renal Replacement Therapy and Veno-Venous Extracorporeal Membrane Oxygenation	13
Blood Pumps for Extracorporeal Membrane Oxygenation: Platelet Activation During Different Operating Conditions	13
High-Versatility Left Ventricle Pump and Aortic Mock Circulatory Loop Development for Patient-Specific Hemodynamic In Vitro Analysis	13
Low-Resistance, Concentric-Gated Pediatric Artificial Lung for End-Stage Lung Failure	13
Central Versus Peripheral Arterial Cannulation for Veno-Arterial Extracorporeal Membrane Oxygenation in Post-Cardiotomy Patients	13
Prothrombin Complex Concentrate for Warfarin Reversal in Patients with Continuous-Flow Left Ventricular Assist Devices: A Narrative Review	12
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Crisis Standards of Care	12
Elevated Venous to Arterial Carbon Dioxide Gap and Anion Gap Are Associated with Poor Outcome in Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation Support	12
Discharge and Readmissions After Ventricular Assist Device Placement in the US Pediatric Hospitals: A Collaboration in ACTION	12
First Clinical Experience With the Pressure Sensor–Based Autoregulation of Blood Flow in an Artificial Heart	12
A Power Tracking Algorithm for Early Detection of Centrifugal Flow Pump Thrombosis	12
Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis	12
Lateral Thoracotomy for Ventricular Assist Device Implantation: A Meta-Analysis of Literature	12
Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Lung Transplantation	12
High Right Ventricular Afterload Is Associated with Impaired Exercise Tolerance in Patients with Left Ventricular Assist Devices	12
In Vitro Testing and Comparison of Additively Manufactured Polymer Impellers for the CentriMag Blood Pump	12
Left Ventricular Assist Device Implantation in Hypertrophic and Restrictive Cardiomyopathy: A Systematic Review	12
Percutaneous Pulmonary Artery Cannulation to Treat Acute Secondary Right Heart Failure While on Veno-venous Extracorporeal Membrane Oxygenation	11
Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic	11
Surgically Implanted Impella Device for Patients on Impella CP Support Experiencing Refractory Hemolysis	11
Improved Drainage Cannula Design to Reduce Thrombosis in Veno-Arterial Extracorporeal Membrane Oxygenation	11
Awake Neonatal Extracorporeal Membrane Oxygenation	11
Use of Hemoadsorption in Patients With Severe Intoxication Requiring Extracorporeal Cardiopulmonary Support—A Case Series	11
Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report	11
Extracorporeal Life Support Organization Guidelines for Fluid Overload, Acute Kidney Injury, and Electrolyte Management	11
Right Heart Failure While on Left Ventricular Assist Device Support Is Associated with Primary Graft Dysfunction	11
Outcomes Following Left Ventricular Assist Device Exchange: Focus on the Impacts of Device Infection	11
Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic	11
Use of Impella in Patients Listed for Heart Transplantation	11
Right Ventricular Global Longitudinal Strain as a Predictor of Acute and Early Right Heart Failure Post Left Ventricular Assist Device Implantation	11
Left Ventricular Flow Dynamics with the HeartMate3 Left Ventricular Assist Device: Effect of Inflow Cannula Position and Speed Modulation	11
Early Fluid Accumulation and Intensive Care Unit Mortality in Children Receiving Extracorporeal Membrane Oxygenation	11
Hemolysis Testing In Vitro: A Review of Challenges and Potential Improvements	11
Anti-thrombotic Therapy With Cangrelor and Bivalirudin in Venoarterial Extracorporeal Membrane Oxygenation Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Experience	10
Platelet, Red Cell, and Endothelial Activation and Injury During Extracorporeal Membrane Oxygenation	10
Pros and Cons of Different Types of Mechanical Circulatory Support Device in Case of Postinfarction Ventricular Septal Defect	10
The Use of Venovenous Extracorporeal Membrane Oxygenation in COVID-19 Infection: One Region’s Comprehensive Experience	10
Incidence and Etiology of System Exchanges in Patients Receiving Extracorporeal Membrane Oxygenation	10
The Current Status of Bioartificial Pancreas Devices	10
The Effects of the Combined Argatroban/Nitric Oxide-Releasing Polymer on Platelet Microparticle-Induced Thrombogenicity in Coated Extracorporeal Circuits	10
Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy	10
Bivalirudin Versus Unfractionated Heparin in Patients With Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation	10
3D Holographic Virtual Surgical Planning for a Single Right Ventricle Fontan Patient Needing Heartmate III Placement	10
Acute Immune Response in Venoarterial and Venovenous Extracorporeal Membrane Oxygenation Models of Rats	10
Arterial Carbon Dioxide and Acute Brain Injury in Venoarterial Extracorporeal Membrane Oxygenation	10
Natural History of Patients Diagnosed with Cardiac Sarcoidosis at Left Ventricular Assist Device Implantation or Cardiac Transplantation	10
HeartWare HVAD Market Withdrawal and Impact on the Pediatric Field	10
Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility	10
Premature and Extracorporeal Life Support: Is it Time? A Systematic Review	10
Impella Management for the Cardiac Intensivist	10
A Review of Extracorporeal Blood Purification Techniques for the Treatment of Critically Ill Coronavirus Disease 2019 Patients	10
Classification of the Frequency, Severity, and Propagation of Thrombi in the HeartMate II Left Ventricular Assist Device	10
Extracorporeal Oxygenation and Coronavirus Disease 2019 Epidemic: Is the Membrane Fail-Safe to Cross Contamination?	10
Right Ventricular Dysfunction is Associated with Increased Mortality in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019	9
Heart Transplantation in Adult Congenital Heart Disease with the Organ Care System Use: A 4-Year Single-Center Experience	9
Poor Reliability of Common Measures of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation	9
Prognostic Value of Sarcopenia for Long-Term Mortality in Extracorporeal Membrane Oxygenation for Acute Respiratory Failure	9
Comparison of Circulatory Unloading Techniques for Venoarterial Extracorporeal Membrane Oxygenation	9
Extracorporeal Membrane Oxygenation for Septic Shock in Children	9
Fluid Balance Management Informs Renal Replacement Therapy Use During Pediatric Extracorporeal Membrane Oxygenation: A Survey Report From the Kidney Intervention During Extracorporeal Membrane Oxygena	9
Extracorporeal Membrane Oxygenation Blood Flow and Blood Recirculation Compromise Thermodilution-Based Measurements of Cardiac Output	9
Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist Devices	9
Venovenous Versus Venoarterial Extracorporeal Membranous Oxygenation in Inotrope Dependent Pediatric Patients With Respiratory Failure	9
Transplant Outcomes in Destination Therapy Left Ventricular Assist Device Patients	9
Centrifugal and Roller Pumps in Neonatal and Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis of Clinical Outcomes	9
Impact of COVID-19 on Patients Supported with a Left Ventricular Assist Device	9
Left Ventricle Unloading Through Pulmonary Artery in Patients With Venoarterial Extracorporeal Membrane Oxygenation	9
International Normalized Ratio Test Frequency in Left Ventricular Assist Device Patients Affects Anticoagulation Quality and Adverse Events	9
Blood Recirculation Enhances Oxygenation Efficiency of Artificial Lungs	9
A Novel Negative Pressure-Flow Waveform to Ventilate Lungs for Normothermic Ex Vivo Lung Perfusion	9
Design and Computational Evaluation of a Pediatric MagLev Rotary Blood Pump	8
Extracorporeal Membrane Oxygenation in Pregnant Women With COVID-19	8
Does Size Matter for Female Continuous-flow LVAD Recipients? A Translational Approach to a Decade Long Question	8
Preoperative Right Heart Dysfunction and Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices	8
Hemodynamic Effects of Concomitant Mitral Valve Surgery and Left Ventricular Assist Device Implantation	8
Mobile Extracorporeal Membrane Oxygenation	8

Neurodevelopmental Outcomes in Extracorporeal Membrane Oxygenation Patients: A Pilot Study	8
Complications of Peripheral Cannulation Site in Obese Patients on Adult Extracorporeal Membrane Oxygenation	8
Recent Era Outcomes of Mechanical Circulatory Support in Children With Congenital Heart Disease as a Bridge to Heart Transplantation	8
Extracorporeal Membrane Oxygenation Circuits in Parallel for Refractory Hypoxemia in COVID-19: A Case Series	8
De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients	8
Heparin Resistance Is Common in Patients Undergoing Extracorporeal Membrane Oxygenation but Is Not Associated with Worse Clinical Outcomes	8
Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices	8
Heart Failure Severity Stratification Beyond INTERMACS Profiles: A Step Toward Optimal Left Ventricular Assist Device Timing	8
Mobile Extracorporeal Membrane Oxygenation for Covid-19 Does Not Pose Extra Risk to Transport Team	8
Primary Graft Dysfunction in Heart Transplant Recipients—Risk Factors and Longitudinal Outcomes	8
Unfractionated Heparin Versus Subcutaneous Nadroparin in Adults Supported With Venovenous Extracorporeal Membrane Oxygenation: a Retrospective, Multicenter Study	8
Safety and Feasibility of an Early Mobilization Protocol for Patients with Femoral Intra-Aortic Balloon Pumps as Bridge to Heart Transplant	8
Impact of CytoSorb Hemoadsorption on Sedation Requirements in Patients With Severe COVID-19 on Venovenous Extracorporeal Membrane Oxygenation	8
2020 EACTS/ELSO/STS/AATS Expert Consensus on Post-cardiotomy Extracorporeal Life Support in Adult Patients	8
Mechanical Blood-Immersed Bearings in Continuous-Flow Rotary Blood Pumps	8
Fluorescence In Situ Hybridization and Polymerase Chain Reaction to Detect Infections in Patients With Left Ventricular Assist Devices	8
Development of New Hemodialysis Catheter Using Numerical Analysis and Experiments	8
Association Between Early Change in Arterial Carbon Dioxide Tension and Outcomes in Neonates Treated by Extracorporeal Membrane Oxygenation	7
The Right Ventricle During Veno-Venous Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome: Can We Protect the Injured Ventricle?	7
SARS-CoV-2 Leakage From the Gas Outlet Port During Extracorporeal Membrane Oxygenation for COVID-19	7
Platelet Transfusion and In-Hospital Mortality in Veno-Arterial Extracorporeal Membrane Oxygenation Patients	7
Hydromorphone Compared to Fentanyl in Patients Receiving Extracorporeal Membrane Oxygenation	7
Interventional Procedures for Left Ventricular Assist Device-Associated Complications	7
The Disconnect Between Extracorporeal Circulation and the Microcirculation: A Review	7
Impact of the Coronavirus Disease 2019 Pandemic on Utilization of Mechanical Circulatory Support As Bridge to Heart Transplantation	7
Microbial Colonization of Oxygenator and Clinical Outcomes in Extracorporeal Membrane Oxygenation	7
Mortality of COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation During the Three Epidemic Waves	7
Increasing Pump Speed During Exercise Training Improves Exercise Capacity in Children with Ventricular Assist Devices	7
Durable Left Ventricular Assist Device as a Bridge to Heart Transplantation Under the New Donor Heart Allocation System	7
Extracorporeal Membrane Oxygenation and Extracorporeal Cardiopulmonary Resuscitation for a COVID-19 Pediatric Patient: A Successful Outcome	7
How to Turn It Down: The Evidence and Opinions Behind Adult Venoarterial Extracorporeal Membrane Oxygenation Weaning	7
Hemodynamic Aspects of Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiac Support: A Worldwide Survey	7
Veno-Venous Extracorporeal Membrane Oxygenation for Children With Cancer or Hematopoietic Cell Transplant: A Ten Center Cohort	7
Neurologic Outcomes After Extracorporeal Cardiopulmonary Resuscitation: Recent Experience at a Single High-Volume Center	7
Acute Kidney Injury and Fluid Overload in Pediatric Extracorporeal Cardio-Pulmonary Resuscitation: A Multicenter Retrospective Cohort Study	7
Hemodilution Increases the Susceptibility of Red Blood Cells to Mechanical Shear Stress During In Vitro Hemolysis Testing	7
Outcomes of Obese Patients Bridged to Heart Transplantation with a Left Ventricular Assist Device	7
Variation in Cardiac Rehabilitation for Pediatric Ventricular Assist Device Recipients Across North America	7
Viscoelastic Coagulation Monitor as a Novel Device to Assess Coagulation at the Bedside. A Single-Center Experience During the COVID-19 Pandemic	7
Sedation Practices of Neonates Receiving Extracorporeal Membrane Oxygenation	7
Veno-Venous Extracorporeal Lung Support as a Bridge to or Through Lung Volume Reduction Surgery in Patients with Severe Hypercapnia	7
Factors Associated With Initiation of Extracorporeal Cardiopulmonary Resuscitation in the Pediatric Population: An International Survey	7
Variability in Blood Pressure Assessment in Patients Supported with the HeartMate 3TM	7
Hemodynamic Effects of Left-Atrial Venous Arterial Extra-Corporeal Membrane Oxygenation (LAVA-ECMO)	7
Percutaneous Axillary Intra-aortic Balloon Pump Insertion Technique as Bridge to Advanced Heart Failure Therapy	7
Stress-Induced (Takotsubo) Cardiomyopathy After Liver Transplant Rescued with Venoarterial Extracorporeal Membrane Oxygenation	6
In-hospital Outcomes of Left Ventricular Assist Devices (LVAD) Patients Undergoing Noncardiac Surgery	6
Detection of Hyponatremia Development in Hemodialysis Patients by Routine Automated Conductivity-Based Monitoring	6
Early Neurological Pupil Index Assessment to Predict Outcome in Cardiac Arrest Patients Undergoing Extracorporeal Membrane Oxygenation	6
Characteristics and Predictors of Late Right Heart Failure After Left Ventricular Assist Device Implantation	6
Development of a Model for the Pediatric Survival After Veno-Arterial Extracorporeal Membrane Oxygenation Score: The Pedi-SAVE Score	6
Variable Sequestration of Antifungals in an Extracorporeal Membrane Oxygenation Circuit	6
In vitro Hemocompatibility Evaluation of the HeartWare Ventricular Assist Device Under Systemic, Pediatric and Pulmonary Support Conditions	6
Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device	6
Exercise Capacity in Mechanically Supported Advanced Heart Failure Patients: It Is All About the Beat	6
Extracorporeal Life Support for Cardiogenic Shock With Either a Percutaneous Ventricular Assist Device or an Intra-Aortic Balloon Pump	6
Fabrication and Characterization of Tissue-Mimicking Phantoms for Ultrasound-Guided Cannulation Training	6
Tissue Factor Pathway Inhibitor Levels During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults	6
Catastrophic Mechanical Complications of Extracorporeal Membrane Oxygenation	6
Prolonged (24-hour) Normothermic ex vivo Heart Perfusion Facilitated by Perfusate Hemofiltration	6
Right Ventricular Injury Increases Mortality in Patients With Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis	6
Lessons Learned from Managing Antithrombotic Therapy in Children Supported with Pediatric Ventricular Assist Devices	6
Early Decompressive Laparotomy for Intra-Abdominal Hypertension Following Initiation of Venovenous Extracorporeal Membrane Oxygenation	6
Recent Changes in Durable Left Ventricular Assist Device Bridging to Heart Transplantation	6
Treatment of HeartMate II Short-to-Shield Patients With an Ungrounded Cable: Indications and Long-Term Outcomes	6
The Effects of Preserving Mitral Valve Function on a Left Atrial Assist Device: An In Vitro Mock Circulation Loop Study	6
Inflow Cannula Position Influences Improvement in Mitral Regurgitation After Ventricular Assist Device Implantation	6
MILESTONE: More Than 1,200 Children Bridged to Heart Transplantation with Mechanical Circulatory Support	6
Ventilation Parameters Before Extracorporeal Membrane Oxygenator and In-Hospital Mortality in Children: A Review of the ELSO Registry	6
Association of Ventilator Settings With Mortality in Pediatric Patients Treated With Extracorporeal Life Support for Respiratory Failure	6
Effect of Timings of the Lavare Cycle on the Ventricular Washout in an In Vitro Flow Visualization Setup	6
Injection of Recombinant Tissue Plasminogen Activator into Extracorporeal Membrane Oxygenators Postpones Oxygenator Exchange in COVID-19	6
Veno-Pulmonary Arterial Extracorporeal Membrane Oxygenation in Severe Acute Respiratory Distress Syndrome: Should We Consider Mechanical Support of the Pulmonary Circulation From the Outset?	6
Prognostic Value of Cardiopulmonary Exercise Test Parameters in Ventricular Assist Device Therapy	6
Association of Volume Status During Veno-Venous Extracorporeal Membrane Oxygenation with Outcome	6
Multilayer Scaling of a Biomimetic Microfluidic Oxygenator	6
Machine Learning in Cardiac Surgery: Predicting Mortality and Readmission	6
Predictors of Survival and Ventricular Recovery Following Acute Myocardial Infarction Requiring Extracorporeal Membrane Oxygenation Therapy	6
A Minimally Invasive Approach to HeartMate 3 Implantation for Systemic Ventricular Failure Following the Mustard Procedure for Transposition of the Great Arteries	6
A Comparison of Anticoagulation Strategies in Veno-venous Extracorporeal Membrane Oxygenation	6
Indwelling Central Venous Catheters Drive Bloodstream Infection During Veno-venous Extracorporeal Membrane Oxygenation Support	6
Gastrointestinal Bleeding Rates in Left Ventricular Assist Device Population Reduced with Octreotide Utilization	6
Chronic Ventricular Assist Device Support in Adult Congenital Heart Disease Patients: A Children’s Hospital Perspective	5
An Intensivist-Led Extracorporeal Membrane Oxygenation Program: Design, Implementation, and Outcomes of the First Five Years	5
Impact of Venoarterial Extracorporeal Membrane Oxygenation Flow on Outcomes in Cardiogenic Shock	5
Electrical Impedance as a Noninvasive Metric of Quality in Allografts Undergoing Normothermic Ex Vivo Lung Perfusion	5
Indication for Venovenous Extracorporeal Membrane Oxygenation: Is 65 Years Old, Too Old?	5
Analysis of Trends and Outcomes of 90 and 180 Day Readmissions After Left Ventricular Assist Device Implantation	5
Ultrasound Measurement of Vascular Distensibility Based on Edge Detection and Speckle Tracking Using Ultrasound DICOM Data	5
Natural History and Prognosis of Patients with Unrepaired Tricuspid Regurgitation Undergoing Implantation of Left Ventricular Assist Device	5
Applications and Outcomes of Extracorporeal Life Support Use in Adult Liver Transplantation: A Case Series and Review of Literature	5
Left Ventricular Assist Device Implantation in Patients with Preoperative Severe Mitral Regurgitation	5
Feasibility of Lung Ultrasound to Monitor Aeration in Children Supported With Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome	5
A Paradigm Shift in Heart Preservation: Improved Post-transplant Outcomes in Recipients of Donor Hearts Preserved With the SherpaPak System	5
Longest Ongoing Support (13 Years) with Magnetically Levitated Left Ventricular Assist Device	5